| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 11/14/2013 | US20130302271 Muscle repair promoter |
| 11/13/2013 | EP2662449A2 Immunoglobulin fusion proteins |
| 11/13/2013 | EP2662448A1 Bone targeted alkaline phosphatase, kits and methods of use thereof |
| 11/13/2013 | EP2662441A1 Method for the in vitro maturation of dendritic cells |
| 11/13/2013 | EP2662090A1 Modified hyaluronidases and uses in treating hyaluronan-associated diseases and conditions |
| 11/13/2013 | EP2662089A2 Compstatin and analogs thereof for eye disorders |
| 11/13/2013 | EP2662088A2 Anti-connexin compounds and uses thereof |
| 11/13/2013 | EP2662087A1 Somatostatin vectors |
| 11/13/2013 | EP2661963A1 Method for diagnosing acute renal failure or chronic renal failure |
| 11/13/2013 | EP2661495A1 Fusion of peptidoglycan hydrolase enzymes to a protein transduction domain allows eradication of both extracellular and intracellular gram positive pathogens |
| 11/13/2013 | EP2661493A1 Plasminogen and plasmin variants |
| 11/13/2013 | EP2661451A1 Antimicrobial fusion compounds and uses thereof |
| 11/13/2013 | EP2661441A1 Process for preparation of caspofungin acetate and intermediates |
| 11/13/2013 | EP2661276A1 Methods and kits for topical application, removal, and inactivation of therapeutic or cosmetic toxin compositions |
| 11/13/2013 | EP2661275A2 Compositions and methods for delivery of high-affinity oxygen binding agents to tumors |
| 11/13/2013 | EP2661272A1 Artificial saliva comprising hyaluronic acid |
| 11/13/2013 | EP2527360A9 Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders |
| 11/13/2013 | EP2229440B9 Recombinant elastase proteins and methods of manufacturing and use thereof |
| 11/13/2013 | CN103392130A Use of acetylated tubulin as a biomarker of drug response to furazanobenzimidazoles |
| 11/13/2013 | CN103392002A Modified plant defensins useful as anti-pathogenic agents |
| 11/13/2013 | CN103392000A Orally administered pharmaceutical composition and preparation method thereof, for the prevention and treatment of irritable bowel syndrome, comprising an intestinal motility modifier and a-d-galactosidase |
| 11/13/2013 | CN103391798A GLP-1 analogue composition for microneedle devices |
| 11/13/2013 | CN103391787A UPAR-antagonists and uses thereof |
| 11/13/2013 | CN103391786A Apolipoprotein A-IV as an antidiabetic peptide |
| 11/13/2013 | CN103391785A Pharmaceutical compositions of tenecteplase |
| 11/13/2013 | CN103391784A Obesity-related genes and their proteins and uses thereof |
| 11/13/2013 | CN103387955A Making method and use of non-human mammal B lymphocyte defect animal model |
| 11/13/2013 | CN103387616A Erythropoietin (EPO) variant-Fc fusion protein |
| 11/13/2013 | CN103387614A Sea anemone Kunitz-type protease inhibitor and application thereof |
| 11/13/2013 | CN103387610A Method for separating and purifying cobra neurotoxin protein through dual-ion exchange chromatography, and preparation of cobra neurotoxin protein |
| 11/13/2013 | CN103387603A Polypeptide related to RTN4B, and preparation and application thereof |
| 11/13/2013 | CN103387602A Novel open-chain tetrapeptide analogue and preparation method and use thereof |
| 11/13/2013 | CN103387601A Anti-dengue virus (DENV) heterocyclic peptide compounds and preparing methods and uses thereof |
| 11/13/2013 | CN103386122A Lumbrokinase enteric-coated tablet and preparation method thereof |
| 11/13/2013 | CN103386121A Medicament for treating dyspepsia, and production technology thereof |
| 11/13/2013 | CN103386120A Traditional Chinese medicine health product containing SOD |
| 11/13/2013 | CN103386119A Application of SIRT1 in adjusting rhythm and improving rhythm disorder |
| 11/13/2013 | CN103386118A Method for controlling organic solvent residue in thymosin alpha 1 microspheres |
| 11/13/2013 | CN103386117A Caspofungin preparation with low impurity content and preparation method and use thereof |
| 11/13/2013 | CN103386116A Compound preparation for controlling bacillary enteritis of young sea bass |
| 11/13/2013 | CN103386115A Application of thymopentin in preparing medicine used for treating mastitis |
| 11/13/2013 | CN103386114A Application of artificial platelet PLAG-PEG-RCD to preparing systemic nanometer styptic for veins |
| 11/13/2013 | CN103385918A Traditional Chinese medicine composition used for treating chronic enteritis, and application thereof |
| 11/13/2013 | CN103385855A Simple rapid microsphere coating method |
| 11/13/2013 | CN103385853A EGF liposome and preparation method thereof |
| 11/13/2013 | CN102816212B Rubiaceae-type cyclopeptide, pharmaceutical composition and application thereof |
| 11/13/2013 | CN102796176B Kunyuenin, preparation method and application |
| 11/13/2013 | CN102586258B Anti-insect peptide of red drum as well as gene cloning method an application thereof |
| 11/13/2013 | CN102552773B Drug for treating bronchitis and bronchial asthma of 7-15 year old children |
| 11/13/2013 | CN102526703B Preparation method and application of nasopharyngeal carcinoma-relevant predisposing gene YH1 protein |
| 11/13/2013 | CN102475893B Method for treating human malignant solid tumor by using hepatocyte nuclear factor-1alpha |
| 11/13/2013 | CN102406921B Medical application of GHGKHKNK octopeptide with anti-tumor synergetic effect on 5-fluorouracil |
| 11/13/2013 | CN102399378B Temperature sensitive chitosan hydrogel and preparation method thereof |
| 11/13/2013 | CN102397529B Compound propolis composition for treating chicken reticuloendotheliosis and preparation method thereof |
| 11/13/2013 | CN102321170B Liraglutide variant and conjugate thereof |
| 11/13/2013 | CN102304516B Pichia pastoris expression product of scygonadin and preparation method thereof |
| 11/13/2013 | CN102174623B Fermentation method and application of yeast engineering bacteria |
| 11/13/2013 | CN102066404B Angiogenic peptide |
| 11/13/2013 | CN101772513B Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders |
| 11/13/2013 | CN101589145B Modified soluble FGF receptor Fc fusions with improved biological activity |
| 11/13/2013 | CN101522711B Reconstituted surfactants having improved properties |
| 11/13/2013 | CN101511382B Selectively targeted antimicrobial peptides and the use thereof |
| 11/13/2013 | CN101495501B Identification, optimization and use of cryptic HLA-B7 epitopes for immunotherapy |
| 11/13/2013 | CN101443001B Method of treatment or prophylaxis inflammatory pain |
| 11/12/2013 | US8581041 Methods of producing GABA |
| 11/12/2013 | US8581040 Methods of producing GABA |
| 11/12/2013 | US8580948 Modulation of forkhead box O1A expression |
| 11/12/2013 | US8580944 Suppressors of CpG oligonucleotides and methods of use |
| 11/12/2013 | US8580941 Epididymal lipocalin gene and uses thereof |
| 11/12/2013 | US8580929 DNA sequence encoding a retinoic acid regulated protein |
| 11/12/2013 | US8580924 Templated native silk smectic gels |
| 11/12/2013 | US8580923 Self-assembling peptide amphiphiles and related methods for growth factor delivery |
| 11/12/2013 | US8580922 Peptide linkers for polypeptide compositions and methods for using same |
| 11/12/2013 | US8580920 Peptides useful for skin lightening |
| 11/12/2013 | US8580919 Polymer conjugates of GLP-1 |
| 11/12/2013 | US8580918 Peptidic GLP-2 agonists |
| 11/12/2013 | US8580761 Bispecific antisense oligonucleotides that inhibit IGFBP-2 and IGFBP-5 and methods of using same |
| 11/12/2013 | US8580754 Genetic inhibition by double-stranded RNA |
| 11/12/2013 | US8580749 Peptide-coated cell localization to diseased or damaged tissues and methods related thereto |
| 11/12/2013 | US8580748 Peptides for the treatment of hearing |
| 11/12/2013 | US8580747 Cyclic natriuretic peptide constructs |
| 11/12/2013 | US8580746 Amide linkage cyclic natriuretic peptide constructs |
| 11/12/2013 | US8580745 Composition for therapeutic and cosmetic botulinum toxin |
| 11/12/2013 | US8580744 Therapeutic formulations containing venom or venom anti-serum either alone or in combination for the therapeutic prophylaxis and therapy of neoplasms |
| 11/12/2013 | US8580743 Modified galectin 9 proteins and methods of treatment using them |
| 11/12/2013 | US8580742 Topical glutathione formulations for menopausal skin |
| 11/12/2013 | US8580741 Cosmetic compositions for skin-tightening and method of skin-tightening using the same |
| 11/12/2013 | US8580740 Bone resorption inhibitory food material for inhibiting bone resorption |
| 11/12/2013 | US8580738 Methods for treatment of reperfusion injury and other cardiac conditions |
| 11/12/2013 | US8580737 Synergistic therapeutic use of prothrombin complex concentrates with FVIII concentrates |
| 11/12/2013 | US8580736 Rspondin polypeptides as promoting factors of angiogenesis and vasculogenesis |
| 11/12/2013 | US8580735 Local complement inhibition for treatment of complement-mediated disorders |
| 11/12/2013 | US8580733 Site-specific monoconjugated insulinotropic GLP-1 peptides |
| 11/12/2013 | US8580732 Peptide therapy for hyperglycemia |
| 11/12/2013 | US8580731 Insulin-gold nanocluster, pharmaceutical composition for reducing blood glucose comprising the same, and method for detecting adipose cells in tissue by using the same |
| 11/12/2013 | US8580557 Casein hydrolyzate, process for producing the same and use thereof |
| 11/12/2013 | US8580553 Phage-associated lytic enzymes for treatment of Bacillus anthracis and related conditions |
| 11/12/2013 | US8580532 Method for stabilizing α-thrombin in thrombin-containing solution |
| 11/12/2013 | US8580321 Method for reducing the effects of chemotherapy using flagellin related polypeptides |
| 11/12/2013 | US8580316 Immune stimulatory infant nutrition |